Skip to content

Stereotaxis STXS PP&E (Net)

PP&E (Net) at other companies

Abbott logo
AbbottABT
$12.38B+13.2%
Boston Scientific logo
Boston ScientificBSX
$4.06B+19.9%
Medtronic logo
MedtronicMDT
$7.42B+8.5%
Stryker logo
StrykerSYK
$3.89B+9.9%
ITG
Integer HoldingsITGR
$533.14M+7.5%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$433.96M+11.2%

Other financials

Income statement

See full
Revenue$6.3M-15.8%
Gross profit$3.8M-6.6%
Operating income-$6.0M-0.9%
Net income-$5.9M-0.7%
EPS (diluted)-$0.06+14.3%

Balance sheet

See full
Cash & equivalents$14.6M+36.7%
Total debt$5.3M-10.0%
Total equity$14.4M+399%
Total assets$54.0M+18.2%

Cash flow

See full
Operating cash flow-$3.4M-93.5%
CapEx$79.0K
Free cash flow-$3.5M

Valuation

See full
Market cap$168.11M-11.6%
Enterprise value$158.77M-15.9%
P/S5.4×-0.6×

Profitability

See full
Gross margin53.9%+0.5pp
Operating margin-71%-14.0pp
Net margin-69.5%-13.7pp
FCF margin-35.5%-2.4pp

Returns & leverage

See full
Return on equity-251.5%-29.9pp
Debt / equity0.4×-1.7×
Current ratio1.6×+0.5×

Where this comes from

Reported directly by Stereotaxis in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Stereotaxis’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stereotaxis's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Stereotaxis's PP&E (net)?
Stereotaxis (STXS) reported PP&E (net) of $2.96M in Q1 2026.
How has Stereotaxis's PP&E (net) changed year-over-year?
Stereotaxis's PP&E (net) decreased by 14.1% year-over-year, from $3.44M to $2.96M.
What is the long-term trend for Stereotaxis's PP&E (net)?
Over 5 years (2020 to 2025), Stereotaxis's PP&E (net) has grown at a 72.9% compound annual growth rate (CAGR), from $195.13K to $3.02M.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.